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Summary  Mucormycosis  is  an  opportunistic,  life-threatening  fungal  infection
caused  by  fungi  of  the  class  Zygomycetes.  The  disease  has  traditionally  been
reported  in  immunocompromised  patients,  premature  infants,  diabetics,  transplant
recipients,  prolonged  use  of  corticosteroids  or  in  condition  associated  with  increased
availability  of  serum  iron  such  as  acidosis  or  deferoxamine  administration.  The  infec-
tion  is  progressive  and  associated  with  a  high  mortality  unless  treatment  is  initiated
promptly.  The  number  of  cases  of  gastrointestinal  mucormycosis  indexed  on  PubMed
over  the  past  2  decades  has  shown  an  alarming  rise.  Moreover,  the  infection  is  being
increasingly  reported  in  patients  without  the  traditional  risk  factors.
We  report  successful  management  of  an  immunocompetent  child  with  gas-
trointestinal  mucormycosis  who  responded  to  aggressive  treatment  with  surgical
debridement  and  antifungal  agents.  The  fungicidal  activity  of  colistin  (polymyxin  E)
has  also  been  highlighted.
©  2012  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.
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hIntroductionMucormycosis  is  an  increasingly  common  oppor-
tunistic,  life-threatening  fungal  infection  that
affects immunocompromised  hosts.  Although  rare,
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http://dx.doi.org/10.1016/j.jiph.2012.08.004t  has  been  reported  in  low-birth-weight  infants  and
as been  shown  to  be  associated  with  a  high  mor-
ality  rate.  However,  infection  in  healthy  persons  is
nusual.
We report  the  successful  management  of
n immunocompetent  child  with  gastrointestinal
ucormycosis  who  responded  to  aggressive  treat-
ent with  surgical  debridement  and  antifungal
gents (amphotericin  B  and  colistin).
 Sciences. Published by Elsevier Ltd. All rights reserved.
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clear) through  the  generation  of  oxidative  metabo-astrointestinal  mucormycosis  
ase history
 10-year-old  boy  weighing  16.3  kg  presented
ith complaints  of  loose  stools  and  progressively
ncreasing distention  of  the  abdomen  for  the  pre-
ious ﬁve  days.  He  also  had  bilious  vomiting  and
n absence  of  stools  or  ﬂatus  for  the  previous  two
ays. He  had  not  passed  urine  for  the  last  13  h.
e complained  of  colicky  pain  in  the  lower  right
uadrant of  the  abdomen  for  the  previous  6 h.  The
atient appeared  ill  and  was  febrile  and  moder-
tely dehydrated.  His  pulse  rate  was  126/min,  his
espiratory  rate  was  30/min  and  his  blood  pres-
ure (mmHg)  was  84/46.  Abdominal  examination
evealed generalized  tenderness  and  absence  of
owel sounds.  Preliminary  laboratory  investigations
evealed hemoglobin  of  8.8  g/dL  with  an  abnormal
oagulation proﬁle.  The  erect  abdominal  radio-
raph  revealed  free  intraperitoneal  air.
While the  patient  was  resuscitated  and  hemo-
ynamically stabilized,  bilateral  ﬂank  drains  were
nserted under  local  anesthesia,  and  approximately
50 mL  of  thick,  deep  yellow,  foul-smelling  pus
as drained.  Vitamin  K  and  fresh  frozen  plasma
ere administered.  An  exploratory  laparotomy  was
erformed  after  stabilization  of  the  hemodynamic
nd coagulation  parameters.  Loculated  pyoperi-
oneum  with  pus  ﬂakes  densely  adherent  to  the
owel  wall  were  present.  A  0.9  cm  ×  0.8  cm  per-
oration was  present  along  the  lateral  border  of
he ascending  colon,  approximately  18  cm  distal  to
he ileocecal  junction.  The  edges  of  the  perforation
ere irregular,  everted,  swollen  and  covered  with
reamy  white  slough.  The  duodenojejunal  junc-
ion was  to  the  right  side  of  the  midline,  and  the
esentery  was  foreshortened.  The  margins  of  the
lcer were  freshened,  and  the  ulcer  was  repaired.
add’s procedure  was  also  performed.  Because  of
evere sepsis  and  edema  of  the  bowel  wall,  a
oop ileostomy  was  performed  15  cm  proximal  to
he ileocecal  junction.  Peritoneal  lavage  was  per-
ormed, and  the  abdomen  was  closed.
The  margins  of  the  ulcer  were  submitted  for
istopathological  examination.  There  were  multi-
le fragments  of  tissue  from  the  ulcer  margin,
evealing large,  deep  mucosal  ulcers  with  marked
ubmucosal  edema  (Fig.  1).  Ulcer  beds  formed  by
ense acute-on-chronic  inﬂammatory  granulation
issue were  observed  to  reach  into  the  muscularis
ropria. Neuromatoid  hyperplasia  was  noted  in  the
yenteric  plexus.  Organized  inﬂammation  in  the
erosa and  a  few  granulomas  with  foreign  body  giant
ells were  also  present.  Multiple  broad  non-septate
yperacute branching  PAS-positive  fungal  hyphae
Periodic  Acid  Schiff  stain)  were  noted  both  in  the
nﬂammatory  exudates  and  within  the  giant  cells.
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he  overall  ﬁndings  were  consistent  with  mucormy-
osis.
The patient  was  initiated  on  intravenous  ampho-
ericin B.  Further  work-up  included  nasal  and
putum swabs,  which  were  negative  for  mucormy-
osis. An  ELISA  test  for  HIV  was  also  negative.  The
atient  remained  in  a  catabolic  phase  and  lost  35%
f his  body  weight  over  the  next  three  weeks,
espite receiving  full  oral  nutrition  and  a high-
rotein  diet.  He  developed  a burst  abdomen  with
leostomy  retraction  and  fecal  ﬁstulae  just  prox-
mal to  the  ileostomy  site  in  the  exposed  bowel,
hich were  repaired  under  general  anesthesia.
he patient  also  developed  left  corneal  ulceration.
either gram  stain  nor  KOH  stain  of  the  corneal
lcer were  suggestive  of  mucormycosis.  The  ulcer
as managed  with  topical  antibiotics  and  artiﬁcial
ears.  The  patient  also  developed  secondary  sep-
is with  methicillin-resistant  Staphylococcus  aureus
hat was  sensitive  to  vancomycin.  The  patient
as initiated  on  injectable  vancomycin,  but  no
ppreciable  response  was  observed  after  ﬁve  days
f antibiotic  treatment.  Based  on  the  report  by
en-Ami  et  al.  [9],  the  patient  was  initiated  on
njectable  colistin  (polymyxin  E).  The  patient  began
o gain  weight  on  the  third  day  of  colistin  treat-
ent, and  his  condition  improved  rapidly.  The
atient  recovered  and  was  discharged  with  a func-
ioning ileostomy.  He  is  awaiting  ileostomy  closure.
iscussion
e  report  the  successful  management  of  a case
f gastrointestinal  mucormycosis  in  a  10-year-old
hild who  was  not  immunocompromised  and  did  not
ave any  of  the  known  predisposing  or  precipitating
actors.
Mucormycosis is  an  opportunistic,  life-
hreatening fungal  infection  caused  by  fungi
f the  class  Zygomycetes  and  order  Mucorales.
hizopus oryzae  (Rhizopus  arrhizus)  is  the  most
ommon  cause  of  mucormycosis  [1].  Mucormycosis
lmost always  occurs  in  patients  with  compromised
mmune function  and  under  conditions  associated
ith the  increased  availability  of  serum  iron.  The
nfection  is  progressive  and  is  associated  with
 high  mortality  unless  treatment  is  initiated
romptly.
Immunity against  mucormycosis  is  provided  by
hagocytes  (both  mononuclear  and  polymorphonu-ites and  cationic  peptide  defensins.  Patients
ith neutropenia  or  dysfunctional  phagocytes  are
herefore  highly  susceptible  to  mucormycosis.
60  P.  Goel  et  al.
Figure  1  Photomicrographs  show  a  large  colonic  ulcer  (A,  H&E  40×),  with  an  acute  inﬂammatory  exudate  containing
many  broad,  aseptate,  acute  angle  branching  fungal  hyphae  (B,  H&E  200×). In  the  granulation  tissue  below  the  ulcer
base  there  are  epithelioid  cell  granulomas  with  giant  cells,  engulﬁng  fungal  hyphae  (C,  H&E  100×). Periodic  Acid
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Ketoacidosis,  diabetes  and  steroid  use  further
impair phagocytic  function  through  unknown  mech-
anisms [2,3].  Furthermore,  an  increased  availability
of serum  iron  increases  the  susceptibility  to
mucormycosis. The  clinical  hallmark  of  mucormy-
cosis is  angioinvasion  with  consequential  systemic
dissemination  of  the  fungal  spores,  thrombosis  of
the affected  blood  vessels  and  local  tissue  infarc-
tion/necrosis  [5].
Mucormycosis  may  be  classiﬁed  as  rhinocerebral,
pulmonary,  cutaneous,  gastrointestinal,  dissemi-
nated or  miscellaneous.  Rhinocerebral  mucormy-
cosis accounts  for  almost  one-third  to  one-half  of
all cases  [5].  Mucormycosis  of  the  gastrointesti-
nal tract  is  rare  [4].  Predisposing  factors  include
malnutrition,  especially  in  infants  and  children  [5].
The fungi  typically  enter  the  gastrointestinal  tract
through ingestion.  The  stomach  is  the  most  common
site of  gastrointestinal  mucormycosis,  followed  by
the colon  and  ileum.  Gastrointestinal  mucormyco-
sis has  been  reported  in  premature  neonates,  with
a presentation  similar  to  that  of  necrotizing  ente-
rocolitis,  and  it  is  often  associated  with  widespread
dissemination.
d
(
mthe  granulomas  as  well  as  in  giant  cells  better  (D,  H&E
Hepatic  mucormycosis  [6]  has  also  been
eported, particularly  after  the  ingestion  of  herbal
edicines.  Maravi-Poma  et  al.  [7]  reported  an
utbreak  of  gastric  mucormycosis  associated  with
he use  of  wooden  tongue  depressors  in  critically
ll patients.
Management  includes  prompt  diagnosis,  the
eversal  of  underlying  predisposing  factors,  aggres-
ive surgical  debridement  of  infected  tissues  and
he initiation  of  antifungal  therapy.  The  diagno-
is is  established  by  demonstrating  characteristic
road, branching  and  non-septated  hyphae  in
reshly infected  tissues,  usually  in  association  with
xtensive angioinvasion,  with  resultant  vascular
hrombosis  and  infarction.  Antigen  detection  is
ssociated with  low  sensitivity  and  speciﬁcity.
Liposomal  amphotericin  B  is  the  drug  of  choice
or treatment  of  mucormycosis;  posaconazole  is
onsidered a  second-line  therapy.  Rifampicin  [8]
as been  shown  to  enhance  the  fungicidal  action
f amphotericin  B.  Ben-Ami  et  al.  [9]  studied  and
emonstrated  the  fungicidal  activity  of  colistin
polymyxin  E)  in  vitro  against  Mucorales  spores  and
ycelia.
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Mucormycosis  is  uniformly  associated  with  high
ortality.  Survival  in  neonates  with  gastrointesti-
al mucormycosis  is  rare  [10—13].  The  lack  of
linical suspicion,  its  association  with  immunocom-
romised status  and  inadequate  therapy  account
or the  high  mortality.  The  mortality  in  pulmonary
ucormycosis approaches  65%  at  1  year  of  age  [14].
isseminated  mucormycosis  is  also  associated  with
ear-total  mortality  because  the  surgical  removal
f infected  tissue  is  not  feasible,  and  most  of  the
ffected patients  are  immunocompromised  [1].
The  successful  management  of  gastrointestinal
ucormycosis  requires  a  high  index  of  suspicion,
iagnostic evaluation  and  the  prompt  initiation  of
ntifungal and  surgical  therapy.  Further  research  is
equired to  establish  the  role  of  colistin  (polymyxin
) in  the  management  of  this  devastating  infection.
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